Collaboration Details

Print  Close


Title of Collaborative Activity:

Microbiological Testing of Live Biotherapeutic Products

Description of Collaborative Activity:

The goal is to bring the purity and potency assays using the novel recombinant protein reagents to scale, as well as to optimize these methods and tools for tech transfer to facilitate the development and regulation of the Live Biotherapeutic Products (LBPs) for preventive and therapeutic use.

Type of Collaborative Activity:

Resource Development

Year the Collaborative Activity Originated:

2012

NIH Participating Institutes/Centers/Office of the Director:

NIAID

HHS Agency Collaborators on this Activity:

FDA